首页> 外文期刊>Diabetes >Akt-Dependent Phosphorylation of Hepatic FoxO1 Is Compartmentalized on a WD40/ProF Scaffold and Is Selectively Inhibited by aPKC in Early Phases of Diet-Induced Obesity
【24h】

Akt-Dependent Phosphorylation of Hepatic FoxO1 Is Compartmentalized on a WD40/ProF Scaffold and Is Selectively Inhibited by aPKC in Early Phases of Diet-Induced Obesity

机译:Akt依赖的肝FoxO1磷酸化是在WD40 / ProF支架上进行的,在饮食诱导的肥胖的早期阶段被aPKC选择性抑制。

获取原文
获取原文并翻译 | 示例
       

摘要

Initiating mechanisms that impair gluconeogenic enzymes and spare lipogenic enzymes in diet-induced obesity (DIO) are obscure. Here, we examined insulin signaling to Akt and atypical protein kinase C (aPKC) in liver and muscle and hepatic enzyme expression in mice consuming a moderate high-fat (HF) diet. In HF diet-fed mice, resting/basal and insulin-stimulated Akt and aPKC activities were diminished in muscle, but in liver, these activities were elevated basally and were increased by insulin to normal levels. Despite elevated hepatic Akt activity, FoxO1 phosphorylation, which diminishes gluco-neogenesis, was impaired; in contrast, Akt-dependent phosphorylation of glycogenic GSK3β and lipogenic mTOR was elevated. Diminished Akt-dependent FoxO1 phosphorylation was associated with reduced Akt activity associated with scaffold protein WD40/Propeller/ FYVE (WD40/ProF), which reportedly facilitates FoxO1 phosphorylation. In contrast, aPKC activity associated with WD40/ProF was increased. Moreover, inhibition of hepatic aPKC reduced its association with WD40/ProF, restored WD40/ProF-associated Akt activity, restored FoxO1 phosphorylation, and corrected excessive expression of hepatic gluconeogenic and lipogenic enzymes. Additionally, Akt and aPKC activities in muscle improved, as did glucose intolerance, weight gain, hepatosteatosis, and hyperlipidemia. We conclude that Akt-dependent FoxO1 phosphorylation occurs on the WD/Propeller/ FYVE scaffold in liver and is selectively inhibited in early DIO by diet-induced increases in activity of cocompart-mentalized aPKC.
机译:在饮食诱导的肥胖症(DIO)中损害糖原异生酶和剩余脂肪原酶的启动机制尚不清楚。在这里,我们检查了食用高脂饮食的小鼠肝脏和肌肉中Akt和非典型蛋白激酶C(aPKC)的胰岛素信号传导和肝酶表达。在HF饮食喂养的小鼠中,肌肉的静息/基础和胰岛素刺激的Akt和aPKC活性降低,但是在肝脏中,这些活性基础升高,并通过胰岛素升高至正常水平。尽管肝Akt活性升高,但FoxO1的磷酸化作用减弱,从而减少了葡萄糖新生。相反,糖原性GSK3β和脂肪生成性mTOR的Akt依赖性磷酸化升高。依赖于Akt的FoxO1磷酸化水平降低与支架蛋白WD40 / Propeller / FYVE(WD40 / ProF)相关的Akt活性降低有关,据报道该蛋白促进FoxO1磷酸化。相反,与WD40 / ProF相关的aPKC活性增加。此外,抑制肝aPKC减少了其与WD40 / ProF的关联,恢复了与WD40 / ProF相关的Akt活性,恢复了FoxO1磷酸化,并纠正了肝糖原异生和脂肪生成酶的过度表达。此外,肌肉中的Akt和aPKC活性得到改善,葡萄糖耐受不良,体重增加,肝脂肪变性和高脂血症也得到改善。我们得出结论,Akt依赖的FoxO1磷酸化发生在肝脏中的WD /螺旋桨/ FYVE支架上,并且在饮食中诱导的同伴精神化aPKC活性增加,在DIO早期受到选择性抑制。

著录项

  • 来源
    《Diabetes》 |2014年第8期|2690-2701|共12页
  • 作者单位

    Medical and Research Services, James A. Haley Veterans Medical Center Tampa, FL,Division of Endocrinology and Metabolism, Department of Internal Medicine, University of South Florida College of Medicine, Tampa, FL;

    Medical and Research Services, James A. Haley Veterans Medical Center Tampa, FL,Division of Endocrinology and Metabolism, Department of Internal Medicine, University of South Florida College of Medicine, Tampa, FL;

    Medical and Research Services, James A. Haley Veterans Medical Center Tampa, FL,Division of Endocrinology and Metabolism, Department of Internal Medicine, University of South Florida College of Medicine, Tampa, FL;

    Medical and Research Services, James A. Haley Veterans Medical Center Tampa, FL,Division of Endocrinology and Metabolism, Department of Internal Medicine, University of South Florida College of Medicine, Tampa, FL;

    Medical and Research Services, James A. Haley Veterans Medical Center Tampa, FL,Division of Endocrinology and Metabolism, Department of Internal Medicine, University of South Florida College of Medicine, Tampa, FL;

    Medical and Research Services, James A. Haley Veterans Medical Center Tampa, FL,Division of Endocrinology and Metabolism, Department of Internal Medicine, University of South Florida College of Medicine, Tampa, FL;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:20

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号